A Phase IIa Study in Primary IgA Nephropathy Patients

Clinical trial NCT07634744 · COMPLETED

Trial details

NCT number: NCT07634744
Sponsor: S-INFINITY Pharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2024-12-31
Primary completion: 2026-04-23
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.